Impact of fertilization history and semen parameters on ICSI outcome.

Published

Journal Article

PURPOSE:The objectives of this study were (1) to investigate intracytoplasmic sperm injection (ICSI) outcome according to its indications, i.e., a history of failed or poor fertilization and unsuitable sperm parameters for conventional IVF, and (2) to examine the impact of a female's age, sperm concentration, motility, morphology, presence of antisperm antibodies, and hemizona assay (HZA) results on overall outcome. METHODS:Two hundred seventy-nine ICSI cycles performed in 207 couples were retrospectively evaluated. RESULTS:Clinical pregnancy and delivery rates were 36.8 and 29.8% for patients with prior failed fertilization, 23.2 and 17.8% for patients who had prior poor fertilization, and 28.6 and 21.3% for patients with unsuitable sperm parameters. The differences among all groups were found to be insignificant. There was a significant, negative correlation between a female's age and pregnancy results. No difference was found in the three basic sperm parameters between those patients who produced and those who did not produce a pregnancy, but the fertilization rate was significantly higher in patients with more adequate sperm parameters. Although there was a trend toward a better fertilization rate in patients with a hemizona index (HZI) greater than 30 (indicative of a superior sperm-zona pellucida binding capacity) than in those with a HZI less than 30, the difference was not significant. There were no differences in fertilization rate according to the presence or absence of antisperm antibodies. CONCLUSIONS:Fertilization history in a conventional IVF cycle has no effect on success rates following ICSI, and there is no correlation among the basic sperm parameters, the presence of antisperm antibodies, and pregnancy rates.

Full Text

Duke Authors

Cited Authors

  • Mercan, R; Oehninger, S; Muasher, SJ; Toner, JP; Mayer, J; Lanzendorf, SE

Published Date

  • January 1998

Published In

Volume / Issue

  • 15 / 1

Start / End Page

  • 39 - 45

PubMed ID

  • 9493065

Pubmed Central ID

  • 9493065

Electronic International Standard Serial Number (EISSN)

  • 1573-7330

International Standard Serial Number (ISSN)

  • 1058-0468

Digital Object Identifier (DOI)

  • 10.1023/A:1022578322024

Language

  • eng